Skip to main content
. 2019 Feb 12;11:1383–1390. doi: 10.2147/CMAR.S188415

Table 2.

Associations of KL expression and DNA methylation with clinicopathologic variables

KL expression KL methylation
Variable n Low Medium High P-value P-trend Low Medium High P-value P-trend
Gender 521 0.271 0.394 0.012 0.04
 Female 137 39 (28.5)a 52 (38.0) 46 (33.6) 32 (23.4) 56 (40.9) 49 (35.8)
 Male 384 135 (35.2) 121 (31.5) 128 (33.3) 141 (36.7) 118 (30.7) 125 (32.6)
Race 506 0.672 0.390 0.775 0.736
 Caucasian 446 146 (32.7) 148 (33.2) 152 (34.1) 148 (33.2) 152 (34.1) 146 (32.7)
 Other 60 23 (38.3) 19 (31.7) 18 (30.0) 20 (33.3) 18 (30.0) 22 (36.7)
Smoking 508 0.282 0.270 0.288 0.115
 No 117 37 (31.6) 34 (29.1) 46 (39.2) 33 (28.2) 39 (33.3) 45 (38.5)
 Yes 391 131 (33.5) 136 (34.8) 124 (31.7) 137 (35.0) 130 (33.3) 124 (31.7)
Stage 507 0.183 0.039 0.520 0.141
 I 20 3 (15.0) 8 (40.0) 9 (45.0) 6 (30.0) 8 (40.0) 6 (30.0)
 II 98 26 (26.5) 32 (32.7) 40 (40.8) 29 (29.6) 34 (34.7) 35 (35.7)
 III 105 42 (40.0) 31 (29.5) 32 (30.5) 30 (28.6) 33 (31.4) 42 (40.0)
 IV 284 97 (34.2) 98 (34.5) 89 (31.3) 105 (37.0) 93 (32.8) 86 (30.3)
Grade 517 0.779 0.223 0.0009 0.0006
 I 63 24 (38.1) 22 (34.9) 17 (27.0) 17 (27.0) 16 (25.4) 30 (47.6)
 II 304 101 (33.2) 102 (33.6) 101 (33.2) 86 (28.3) 115 (37.8) 103 (33.9)
 III 150 47 (31.3) 49 (32.7) 54 (36.0) 67 (44.7) 42 (28.0) 41 (27.3)
Tumor site 521 <0.0001 <0.0001 <0.0001 <0.0001
 Tongue 200 52 (26.0) 60 (30.0) 88 (44.0) 79 (39.5) 72 (36.0) 49 (24.5)
 Pharynx 135 39 (28.9) 52 (38.5) 44 (32.6) 53 (39.3) 45 (33.3) 37 (27.4)
 Other 186 83 (44.6) 61 (32.8) 42 (22.6) 41 (22.0) 57 (30.7) 88 (47.3)

Note:

a

n (%).